LVTX icon

LAVA Therapeutics

14 hedge funds and large institutions have $9.26M invested in LAVA Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
5
Closed
2
Calls
$34K
Puts
Net Calls
+$34K
Net Calls Change
+$9K
Name Holding Trade Value Shares
Change
Shares
Change %
RG
1
Redmile Group
California
$3.28M
NHAS
2
Novo Holdings A/S
Denmark
$2.97M -$824K -521,806 -22%
TCM
3
Tang Capital Management
California
$1.33M +$1.33M +840,593 New
BC
4
Bruce & Co
Illinois
$1.22M
AWG
5
Alpha Wave Global
New York
$170K -$1.88K -1,191 -1%
PNC Financial Services Group
6
PNC Financial Services Group
Pennsylvania
$103K
Morgan Stanley
7
Morgan Stanley
New York
$78.4K +$62.1K +39,300 +382%
Millennium Management
8
Millennium Management
New York
$44.3K -$56.8K -35,946 -56%
Citadel Advisors
9
Citadel Advisors
Florida
$34.1K +$34.1K +21,552 New
TRCT
10
Tower Research Capital (TRC)
New York
$18.1K -$790 -500 -4%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$17.6K
TFGT
12
TS Financial Group (TSFG)
Illinois
$1K
Group One Trading
13
Group One Trading
Illinois
$158
AG
14
Artal Group
Luxembourg
-$294K -200,000 Closed
Osaic Holdings
15
Osaic Holdings
Arizona
-$71 -48 Closed